Cargando…
Cell-Free DNA in Cerebrospinal Fluid Complements the Monitoring Value of Interleukin-10 in Newly Diagnosed Primary Central Nervous System Lymphoma
OBJECTIVES: Primary central nervous system lymphoma (PCNSL) usually has a poor prognosis. Cerebrospinal fluid (CSF) interleukin (IL)-10 has shown diagnostic, prognostic, and monitoring value in our previous studies. Cell-free circulating tumor DNA can be detected in the CSF of refractory/relapse cas...
Autores principales: | Wang, Wei, Zou, DongMei, Zhuang, Zhe, Zhang, Xiao, Zhang, Li, Yin, JingJing, Jia, CongWei, Yuan, Li, Cai, Hao, Zhang, Yan, Wang, Xuan, Zhang, MeiFen, Zhou, DaoBin, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836788/ https://www.ncbi.nlm.nih.gov/pubmed/36644235 http://dx.doi.org/10.1155/2023/5808731 |
Ejemplares similares
-
Changes in cerebrospinal fluid interleukin-10 levels display better performance in predicting disease relapse than conventional magnetic resonance imaging in primary central nervous system lymphoma
por: Zhang, Yan, et al.
Publicado: (2021) -
Circulating cell-free DNA and IL-10 from cerebrospinal fluids aid primary vitreoretinal lymphoma diagnosis
por: Zhuang, Zhe, et al.
Publicado: (2022) -
Corrigendum: Circulating cell-free DNA and IL-10 from cerebrospinal fluids aid primary vitreoretinal lymphoma diagnosis
por: Zhuang, Zhe, et al.
Publicado: (2023) -
Lenalidomide and Rituximab Regimen Combined With Intravitreal Methotrexate Followed by Lenalidomide Maintenance for Primary Vitreoretinal Lymphoma: A Prospective Phase II Study
por: Zhang, Yan, et al.
Publicado: (2021) -
Preliminary Evaluation of Zanubrutinib-Containing Regimens in DLBCL and the Cerebrospinal Fluid Distribution of Zanubrutinib: A 13-Case Series
por: Zhang, Yan, et al.
Publicado: (2021)